At 7 years of age, children exposed to maternal depression during pregnancy or SSRI antidepressants exhibited similar changes in white matter architecture.
A wide range of delivery options may be effective for addressing symptoms of depression in perinatal individuals, and could therefore be leveraged to expand access to treatments.
Compared to individuals with histories of psychiatric illness prior to pregnancy, perinatal individuals without a prepregnancy psychiatric history were less likely to be screened, referred, and treated for depression.
Psychological interventions may reduce the severity of perinatal anxiety symptoms.
There is evidence that screening for perinatal mood and anxiety disorders may improve outcomes; however, success depends on adequate resources for screening, diagnosis, treatment and follow-up.
 Some good news from our colleagues at the Maternal Mental Health Leadership Alliance (MMHLA)... The United States Department of Health and Human Services (HHS) is planning to launch significant initiatives addressing the maternal mental [...]
This hotline will offer a range of support, including brief interventions, referrals to both community-based and telehealth providers as needed.
Imagine if we could use machine learning to enhance the care we deliver, analyzing a larger body of patient-specific factors in order to make more reliable predictions of risk for perinatal mood and anxiety disorders.
Addressing sleep problems may be an important component of suicide prevention efforts, as improving sleep quality and duration may help to reduce the risk of suicide in perinatal population.
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on transcranial magnetic stimulation during pregnancy with Ob.Gyn News on May 4th.
